The North America In Vitro Toxicity Testing Market would witness market growth of 10.1% CAGR during the forecast period (2022-2028).
In vitro toxicology examines the harmful characteristics of substances and combinations utilizing cells sustained or developed in controlled laboratory settings. This allows everyone to analyze xenobiotic toxicity at the cellular level without the interference of multiple physiological systemic effects which are frequently found in whole organisms. Primary cultures of cells from certain tissues, such as the liver for xenobiotic biotransformation, kidney or gills for ionic homeostasis, and nerve cells for neurotransmitter signaling effects, could be used to investigate specific cellular processes.
By adopting technologies employed by the pharmaceutical companies in human clinical trials, it may be feasible to get more understanding into individual in vivo mechanisms and processes, as well as assess the significance of in vitro identified mechanisms such as, micro-dosing and tracing studies. Data extension from a healthy to a clinical condition may be possible with a greater knowledge of the processes and pathways involved.
Markers and marker statuses with sufficient ability to predict toxicity including potency and efficacy in the case of medications are in high demand. Specific gene clusters have been found and examined for a variety of disorders such as allergies, chronic diseases, and cancer. Simulation of gene clusters has improved the insight into the mechanisms underlying clinical diseases, and diagnostic indicators have been discovered.
Technical developments and favorable regulatory changes have spurred the advancement of innovative, cost-effective testing for evaluating medication, device, chemical, and cosmetic safety in North America over the last few years. Clients can build toxicological analyses of biopharmaceuticals, medical equipment, cosmetics, and chemicals due to a major increase in equipment and the continued growth of laboratory capacities across the region. The extension of current cell/tissue flow cytometry, culture abilities, and spectrometry facilities, as well as the adoption of rapid detection, multiplexing, and automatic technologies for biomarkers analysis, are all part of these initiatives.
According to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals (GHS), a skin sensitizer, is a substance or mixture that causes an allergic reaction when it comes into contact with the skin. A chemical's propensity to elicit allergic contact dermatitis, a local skin response characterized by redness, swelling, and itching, is determined through skin sensitization testing.
The US market dominated the North America In Vitro Toxicity Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $10.0 billion by 2028. The Canada market is experiencing a CAGR of 12.6% during (2022 - 2028). Additionally, The Mexico market is expected to would witness a CAGR of 11.6% during (2022 - 2028).
Based on Type, the market is segmented into Absorption, Toxic Substances, and Dose. Based on Technology, the market is segmented into Cell Culture Technologies, High Throughput Technologies, and Toxicogenomics. Based on End User, the market is segmented into Cosmetics & Households Products, Pharmaceuticals Industry, Food Industry, Chemicals, and Industry. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global In Vitro Toxicity Testing Market is Estimated to reach $37.5 Billion by 2028, at a CAGR of 10.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., General Electric (GE) Co., AstraZeneca PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Acacia Pharma Group Plc, GlaxoSmithKline PLC, Helsinn Healthcare SA., and Heron Therapeutics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Absorption
- Toxic Substances
- Dose
By Technology
- Cell Culture Technologies
- High Throughput Technologies
- Toxicogenomics
By End User
- Cosmetics & Households Products
- Pharmaceuticals Industry
- Food Industry
- Chemicals Industry
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- General Electric (GE) Co.
- AstraZeneca PLC
- Catalent, Inc.
- Laboratory Corporation of America Holdings
- Acacia Pharma Group Plc
- GlaxoSmithKline PLC
- Helsinn Healthcare SA.
- Heron Therapeutics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America In Vitro Toxicity Testing Market, by Type
1.4.2 North America In Vitro Toxicity Testing Market, by Technology
1.4.3 North America In Vitro Toxicity Testing Market, by End User
1.4.4 North America In Vitro Toxicity Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America In Vitro Toxicity Testing Market by Type
3.1 North America Absorption Market by Country
3.2 North America Toxic Substances Market by Country
3.3 North America Dose Market by Country
Chapter 4. North America In Vitro Toxicity Testing Market by Technology
4.1 North America Cell Culture Technologies Market by Country
4.2 North America High Throughput Technologies Market by Country
4.3 North America Toxicogenomics Market by Country
Chapter 5. North America In Vitro Toxicity Testing Market by End User
5.1 North America Cosmetics & Households Products Market by Country
5.2 North America Pharmaceuticals Industry Market by Country
5.3 North America Food Industry Market by Country
5.4 North America Chemicals Industry Market by Country
Chapter 6. North America In Vitro Toxicity Testing Market by Country
6.1 US In Vitro Toxicity Testing Market
6.1.1 US In Vitro Toxicity Testing Market by Type
6.1.2 US In Vitro Toxicity Testing Market by Technology
6.1.3 US In Vitro Toxicity Testing Market by End User
6.2 Canada In Vitro Toxicity Testing Market
6.2.1 Canada In Vitro Toxicity Testing Market by Type
6.2.2 Canada In Vitro Toxicity Testing Market by Technology
6.2.3 Canada In Vitro Toxicity Testing Market by End User
6.3 Mexico In Vitro Toxicity Testing Market
6.3.1 Mexico In Vitro Toxicity Testing Market by Type
6.3.2 Mexico In Vitro Toxicity Testing Market by Technology
6.3.3 Mexico In Vitro Toxicity Testing Market by End User
6.4 Rest of North America In Vitro Toxicity Testing Market
6.4.1 Rest of North America In Vitro Toxicity Testing Market by Type
6.4.2 Rest of North America In Vitro Toxicity Testing Market by Technology
6.4.3 Rest of North America In Vitro Toxicity Testing Market by End User
Chapter 7. Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 General Electric (GE) Co.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 AstraZeneca PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Catalent, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Laboratory Corporation of America Holdings (Covance, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Acquisition and Mergers:
7.6 Acacia Pharma Group Plc
7.6.1 Company Overview
7.7 GlaxoSmithKline PLC (TESARO, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Helsinn Healthcare SA.
7.8.1 Company Overview
7.9 Heron Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
TABLE 1 North America In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 2 North America In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 3 North America In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 4 North America In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 5 North America Absorption Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Absorption Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Toxic Substances Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Toxic Substances Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Dose Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Dose Market by Country, 2022 - 2028, USD Million
TABLE 11 North America In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 12 North America In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 13 North America Cell Culture Technologies Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Cell Culture Technologies Market by Country, 2022 - 2028, USD Million
TABLE 15 North America High Throughput Technologies Market by Country, 2018 - 2021, USD Million
TABLE 16 North America High Throughput Technologies Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Toxicogenomics Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Toxicogenomics Market by Country, 2022 - 2028, USD Million
TABLE 19 North America In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 North America In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 North America Cosmetics & Households Products Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Cosmetics & Households Products Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Pharmaceuticals Industry Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Pharmaceuticals Industry Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Food Industry Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Food Industry Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Chemicals Industry Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Chemicals Industry Market by Country, 2022 - 2028, USD Million
TABLE 29 North America In Vitro Toxicity Testing Market by Country, 2018 - 2021, USD Million
TABLE 30 North America In Vitro Toxicity Testing Market by Country, 2022 - 2028, USD Million
TABLE 31 US In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 32 US In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 33 US In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 34 US In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 35 US In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 36 US In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 37 US In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 38 US In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 39 Canada In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 40 Canada In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 41 Canada In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 42 Canada In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 43 Canada In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 44 Canada In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 45 Canada In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 46 Canada In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 47 Mexico In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 48 Mexico In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 49 Mexico In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 50 Mexico In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 51 Mexico In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 52 Mexico In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 53 Mexico In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 54 Mexico In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 55 Rest of North America In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 56 Rest of North America In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 57 Rest of North America In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 58 Rest of North America In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 59 Rest of North America In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 60 Rest of North America In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 61 Rest of North America In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 62 Rest of North America In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 63 Key Information – Thermo Fisher Scientific, Inc.
TABLE 64 KEY INFORMATION – GENERAL ELECTRIC (GE) CO.
TABLE 65 KEY INFORMATION – ASTRAZENECA PLC
TABLE 66 Key information – CATALENT, INC.
TABLE 67 Key Information – Laboratory Corporation of America holdings
TABLE 68 Key Information – Acacia Pharma Group Plc
TABLE 69 Key Information – GlaxoSmithKline PLC
TABLE 70 Key Information – Helsinn Healthcare SA.
TABLE 71 Key Information – Heron Therapeutics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: thermo fisher scientific, inc.
FIG 3 Swot analysis: General electric (GE) Co.